Université d'Abomey-Calavi Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2020
NCT04386070
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Université d'Abomey-Calavi